Frequency Therapeutics Inc.

2.00-0.2500-11.11%Vol 159.21K1Y Perf -73.09%
Aug 9th, 2022 16:00 DELAYED
BID1.96 ASK2.09
Open2.27 Previous Close2.25
Pre-Market- After-Market2.09
 - -  0.09 4.50%
Target Price
8.00 
Analyst Rating
Moderate Buy 1.67
Potential %
300.00 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★+     48.78
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★     43.91
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
13.42 
Earnings Rating
Market Cap69.95M 
Earnings Date
11th Aug 2022
Alpha-0.03 Standard Deviation0.25
Beta0.54 

Today's Price Range

2.002.27

52W Range

1.008.45

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
17.19%
1 Month
19.05%
3 Months
77.17%
6 Months
-53.89%
1 Year
-73.09%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
FREQ2.00-0.2500-11.11
AAPL164.920.05000.03
GOOG117.50-0.6400-0.54
MSFT282.301.98000.71
XOM90.591.64001.84
WFC43.400.21000.49
JNJ170.18-0.0200-0.01
FB196.640.99000.51
GE74.93-0.2500-0.33
JPM115.381.03000.90
 
ProfitabilityValueIndustryS&P 500US Markets
-
-923.30
-890.20
-
-72.67
RevenueValueIndustryS&P 500US Markets
0.00
0.00
-
-
Earnings HistoryEstimateReportedSurprise %
Q01 2022-0.66-0.67-1.52
Q04 20210.37-0.62-267.57
Q03 2021-0.55-0.73-32.73
Q02 2021-0.51-0.52-1.96
Q01 2021-0.27-0.60-122.22
Q04 2020-0.30-0.300.00
Q03 2020-0.32-0.1650.00
Q02 2020-0.22-0.1913.64
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date11th Aug 2022
Estimated EPS Next Report-0.69
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume159.21K
Shares Outstanding34.98K
Shares Float32.24M
Trades Count1.71K
Dollar Volume333.71K
Avg. Volume432.23K
Avg. Weekly Volume235.01K
Avg. Monthly Volume487.82K
Avg. Quarterly Volume573.86K

Frequency Therapeutics Inc. (NASDAQ: FREQ) stock closed at 2.25 per share at the end of the most recent trading day (a 0.9% change compared to the prior day closing price) with a volume of 132.36K shares and market capitalization of 69.95M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 47 people. Frequency Therapeutics Inc. CEO is David L. Lucchino.

The one-year performance of Frequency Therapeutics Inc. stock is -73.09%, while year-to-date (YTD) performance is -56.14%. FREQ stock has a five-year performance of %. Its 52-week range is between 1 and 8.45, which gives FREQ stock a 52-week price range ratio of 13.42%

Frequency Therapeutics Inc. currently has a PE ratio of -0.90, a price-to-book (PB) ratio of 0.70, a price-to-sale (PS) ratio of 5.42, a price to cashflow ratio of 28.20, a PEG ratio of 2.32, a ROA of -43.15%, a ROC of -45.86% and a ROE of -60.46%. The company’s profit margin is -72.67%, its EBITDA margin is -890.20%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Frequency Therapeutics Inc., there were 0 positive earnings surprise and 4 negative earnings surprise. The company has EPS estimate of $-0.69 for the next earnings report. Frequency Therapeutics Inc.’s next earnings report date is 11th Aug 2022.

The consensus rating of Wall Street analysts for Frequency Therapeutics Inc. is Moderate Buy (1.67), with a target price of $8, which is +300.00% compared to the current price. The earnings rating for Frequency Therapeutics Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Frequency Therapeutics Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Frequency Therapeutics Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 23.26, ATR14 : 0.22, CCI20 : 48.87, Chaikin Money Flow : -0.01, MACD : 0.13, Money Flow Index : 66.56, ROC : 2.27, RSI : 46.31, STOCH (14,3) : 83.71, STOCH RSI : 1.00, UO : 41.21, Williams %R : -16.29), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Frequency Therapeutics Inc. in the last 12-months were: Carl P. LeBel (Option Excercise at a value of $0), Carl P. LeBel (Sold 9 040 shares of value $25 375 ), Christopher R. Loose (Option Excercise at a value of $0), Christopher R. Loose (Sold 9 072 shares of value $25 581 ), David L. Lucchino (Option Excercise at a value of $16 848), Peter P. Pfreundschuh (Option Excercise at a value of $0), Peter P. Pfreundschuh (Sold 6 818 shares of value $27 605 ), Quentin McCubbin (Option Excercise at a value of $0), Quentin McCubbin (Sold 13 361 shares of value $37 436 ), Richard M. Mitrano (Option Excercise at a value of $0), Richard M. Mitrano (Sold 2 184 shares of value $3 363 ), Wendy S. Arnold (Option Excercise at a value of $0), Wendy S. Arnold (Sold 11 516 shares of value $32 365 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (66.67 %)
2 (50.00 %)
3 (75.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (33.33 %)
1 (25.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
1 (25.00 %)
1 (25.00 %)
Summary RatingModerate Buy
1.67
Moderate Buy
2.50
Moderate Buy
2.00

Frequency Therapeutics Inc.

Frequency Therapeutics Inc is a clinical-stage biotechnology company focused on harnessing the body's innate biology to repair or reverse damage caused by degenerative diseases. Its Progenitor Cell Activation approach uses combinations of molecules to activate progenitor cells within the body to create functional tissue. Its product candidate FX-322 is being developed for treating sensorineural hearing loss.

CEO: David L. Lucchino

Telephone: +1 866 389-1970

Address: 19 Presidential Way, Woburn 01801, MA, US

Number of employees: 47

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

62%38%

Bearish Bullish

55%45%

Bearish Bullish

57%43%


News

Stocktwits